Find Clinical Trial

Home » Find Clinical Trials » A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelling, as assessed on an alveolar bone biopsy extracted before dental implantation, in osteoporotic patients or in patients at risk of osteoporotic fracture.

A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelling, as assessed on an alveolar bone biopsy extracted before dental implantation, in osteoporotic patients or in patients at risk of osteoporotic fracture.

← Back

Study Phase	Phase 2

Therapeutic Area	Rheumatology

Indication	Other

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	STRONTIUM RANELATE, S012911

Active Substance Code	S012911

Protocol Code	CL2-12911-039

EudraCT Code	2011-002370-23

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.